TrialCanadian journal of gastroenterology & hepatology2014

Single-dose infliximab in hepatitis C genotype 1 treatment-naive patients with high serum tumour necrosis factor-alpha does not influence the efficacy of pegylated interferon alpha-2b/ribavirin therapy.

Curtis Cooper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.